TCT 129: Primary Results of the Mini-C First-in-Human Study of a Novel Non-Balloon-Based Coronary Intravascular Lithotripsy System

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Shockwave Medical; Boston Scientific Corporation</li><li>Equity/Stock(s)/Options - Seigla Medical</li></ul>